|
|
Normal
Press Release
| November 3, 2004 |
November 3, 2004
Westaim announces 2004 third quarter results
|
| October 6, 2004 |
October 6, 2004
The Westaim Corporation appoints Dr. Roger G.H. Downer
to the Board of Directors
|
| September 7, 2004 |
September 7, 2004
Westaim’s NUCRYST Pharmaceuticals reports Phase 2a clinical trial results of investigational drug in atopic dermatitis
|
| August 9, 2004 |
August 9, 2004
Westaim announces 2004 second quarter results
|
| August 4, 2004 |
August 4, 2004
The Westaim Corporation announces closing of equity financing
|
| July 14, 2004 |
July 14, 2004
Westaim to raise $34 million through bought deal to fund iFire pilot production
|
| May 5, 2004 |
May 5, 2004
Westaim announces 2004 first quarter results
|
| February 19, 2004 |
February 19, 2004
Westaim announces 2003 year-end results
|
| January 30, 2004 |
January 30, 2004
Westaim sells Ambeon division for $35 million
|
|
|